http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Late-Breaking Registry Data at EuroPCR Congress Demonstrate Reduced Paravalvular Leak and Low Permanent Pacemaker Rates for the ACURATE neo2™ Aortic Valve System
-
Boston Scientific Announces May Conference Schedule
-
Boston Scientific Announces Results For First Quarter 2021
-
Boston Scientific Announces Conference Call Discussing First Quarter 2021 Results and Participation in Truist Securities 2021 Life Sciences Summit
-
Late-Breaking Clinical Trial Data for TheraSphere™ Y-90 Glass Microspheres Demonstrates Improved Survival in Primary Liver Cancer
-
Boston Scientific (BSX) Receives FDA Approval for TheraSphere Y-90 Glass Microspheres
-
Boston Scientific Receives FDA Approval for TheraSphere™ Y-90 Glass Microspheres
-
Boston Scientific (BSX) To Acquire Lumenis LTD. Surgical Business From Baring Private Equity Asia for $1.07 Billion Upfront
-
Boston Scientific Announces Agreement To Acquire Lumenis LTD. Surgical Business From Baring Private Equity Asia
-
Boston Scientific Announces February and March 2021 Conference Schedule
-
Boston Scientific Announces Results For Fourth Quarter And Full Year 2020
-
Boston Scientific (BSX) Receives FDA Approval For The Vercise Genus Deep Brain Stimulation System
-
Boston Scientific Receives FDA Approval For The Vercise Genus™ Deep Brain Stimulation System
-
Boston Scientific (BSX) to Acquire Preventice Solutions, Inc. for $925M Upfront Plus $300M in Milestone Payments
-
Boston Scientific Announces Agreement To Acquire Preventice Solutions, Inc.
-
Boston Scientific Launches WaveWriter Alpha™ Spinal Cord Stimulator Systems In U.S.
-
Boston Scientific (BSX) Prelim. Q4 Revenue Misses Consensus
-
Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year 2020
-
Boston Scientific to Participate in J.P. Morgan Healthcare Conference and Announces Conference Call Discussing Fourth Quarter 2020 Results
-
Boston Scientific Announces Stipulation Of Dismissal Of Nevro Corporation's Patent Infringement Case In California
-
Boston Scientific (BSX) to Divest BTG Specialty Pharmaceuticals Business
-
Boston Scientific Signs Definitive Agreement to Divest BTG Specialty Pharmaceuticals Business
-
Boston Scientific to Participate in Evercore ISI 2020 Healthcare Conference
-
Boston Scientific (BSX) Announces LOTUS Edge Aortic Valve System Voluntary Recall and Product Discontinuation
-
Boston Scientific Announces LOTUS Edge™ Aortic Valve System Voluntary Recall and Product Discontinuation
-
Appaloosa's 13F Shows Decrease in Alibaba (BABA), Increase in Micron (MU) and Microsoft (MSFT) (more...)
-
Boston Scientific Announces November 2020 Conference Schedule
-
Boston Scientific (BSX) Receives FDA Approval for the Ranger Drug-Coated Balloon
-
Boston Scientific Receives FDA Approval for the Ranger™ Drug-Coated Balloon
-
Boston Scientific Initiates Trial to Evaluate WATCHMAN FLX™ Left Atrial Appendage Closure Device as First-Line Treatment for People at Risk of Stroke
-
Boston Scientific Announces Results For Third Quarter 2020
-
Boston Scientific Announces Transcatheter Cardiovascular Therapeutics 2020 Investor Update and Conference Call Discussing Third Quarter 2020 Results
-
Boston Scientific Launches WaveWriter Alpha™ Spinal Cord Stimulator Systems In Europe
-
Boston Scientific Launches ACURATE neo2™ Aortic Valve System in Europe
-
Boston Scientific (BSX) Announces Expanded Investment and Exclusive Acquisition Option Agreement with Farapulse, Inc.
-
Boston Scientific Announces Expanded Investment and Exclusive Acquisition Option Agreement with Farapulse, Inc.
-
Boston Scientific Launches Vercise Genus™ DBS System In Europe
-
Boston Scientific (BSX) Announces CMS Grants Additional Reimbursement For The Eluvia Drug-Eluting Vascular Stent System
-
CMS Grants Additional Reimbursement For The Eluvia™ Drug-Eluting Vascular Stent System
-
Boston Scientific Announces September 2020 Conference Schedule
-
Appaloosa's 13F Shows New Stakes in Altria (MO), AT&T Inc (T), Disney (DIS), PayPal (PYPL) (More...)
-
Alydia Announces $13.9 Million Financing for Innovative Postpartum Hemorrhage Treatment, Appoints Robert Binney as CEO and Colby Holtshouse as COO
-
Boston Scientific Announces Results For Second Quarter 2020
-
Boston Scientific (BSX) Granted FDA Approval for Next-Generation WATCHMAN FLX Left Atrial Appendage Closure Device
-
Boston Scientific Receives FDA Approval for Next-Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device
-
Boston Scientific Announces Conference Call Discussing Second Quarter 2020 Financial Results
-
Boston Scientific (BSX) Receives FDA 510(k) Clearance for the LUX-Dx Insertable Cardiac Monitor System
-
Boston Scientific Receives FDA 510(k) Clearance for the LUX-Dx™ Insertable Cardiac Monitor System
-
Boston Scientific (BSX) Announces Medicare Transitional Pass-Through Payment for EXALT Model D Single-Use Duodenoscope
-
Boston Scientific Receives Medicare Transitional Pass-Through Payment for the EXALT™ Model D Single-Use Duodenoscope

